Literature DB >> 7995290

Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies.

K Kasagi1, H Hatabu, S Miyamoto, R Takeuchi, T Misaki, H Sakahara, Y Iida, J Konishi.   

Abstract

The present study was designed to analyse the scintigraphic appearance of the thyroid in hypothyroid patients with blocking-type TSH receptor antibodies (TRAbs). Eleven hypothyroid patients with autoimmune thyroiditis positive for TSH binding inhibitor immunoglobulins (TBII) [80% +/- 12 (SD)%; normal < 11%] and for thyroid stimulation-blocking antibodies (TSBAbs) (90% +/- 9%: normal < 32%) were studied. Thyroid scanning was performed using technetium-99m or iodine-123, when the patients were hypothyroid. Analysis of the scan images revealed the presence of localized functioning areas in six patients (group 1), and no visualization of the thyroid in the remaining five patients (group 2). Patients in group 1 showed significantly higher uptake of 99mTc than those in group 2 (P < 0.05). Interestingly, three patients in group 1 were positive for thyroid-stimulating antibodies (TSAbs) (249% +/- 17%; normal < 145%), which were not detected in the remaining eight patients. Antibodies against thyroglobulin and microsomal antigens were detected in nine nine (81.8%) and 11 (100%) patients, respectively, but neither of these titres correlated with the scan image. Three patients in group 1 underwent scintigraphy again after treatment with thyroxine, at which time the functioning lesion was not noted. Fourteen hypothyroid patients with negative TBII displayed no such scintigraphic findings. Chronic stimulation of the thyroid by TSAbs and/or TSH might be responsible for the presence of the functioning lesion, but clarification of the mechanism requires further studies. In summary (1) TSAbs were detected in three (27.3%) of 11 hypothyroid patients with blocking TRAbs; (2) thyroid scintigraphy revealed the presence of localized functioning area(s) in approximately half of these cases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995290     DOI: 10.1007/BF00238120

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  21 in total

1.  THE THYROID SCINTIGRAM. I. THE HOT NODULE.

Authors:  J M MILLER; J I HAMBURGER
Journal:  Radiology       Date:  1965-01       Impact factor: 11.105

2.  A sensitive thyrotropin (TSH) bioassay based on iodide uptake in rat FRTL-5 thyroid cells: comparison with the adenosine 3',5'-monophosphate response to human serum TSH and enzymatically deglycosylated bovine and human TSH.

Authors:  M Nissim; K O Lee; P A Petrick; P A Dahlberg; B D Weintraub
Journal:  Endocrinology       Date:  1987-10       Impact factor: 4.736

3.  Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins.

Authors:  J Konishi; K Kasagi; Y Iida; T Kousaka; T Misaki; K Arai; Y Tokuda; K Torizuka
Journal:  Endocrinol Jpn       Date:  1987-02

4.  Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.

Authors:  B Y Cho; Y K Shong; H K Lee; C S Koh; H K Min
Journal:  Acta Endocrinol (Copenh)       Date:  1989-01

5.  Toxic nodular goitre.

Authors:  H Studer; H J Peter; H Gerber
Journal:  Clin Endocrinol Metab       Date:  1985-05

6.  Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients.

Authors:  J Konishi; Y Iida; K Kasagi; T Misaki; T Nakashima; K Endo; T Mori; S Shinpo; Y Nohara; N Matsuura
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

7.  Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.

Authors:  S Kosugi; T Ban; T Akamizu; W Valente; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

8.  Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis.

Authors:  N Takasu; T Yamada; M Takasu; I Komiya; Y Nagasawa; T Asawa; T Shinoda; T Aizawa; Y Koizumi
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

9.  Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  K Endo; K Kasagi; J Konishi; K Ikekubo; T Okuno; Y Takeda; T Mori; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

10.  In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies.

Authors:  N Amino; Y Watanabe; H Tamaki; Y Iwatani; K Miyai
Journal:  Clin Endocrinol (Oxf)       Date:  1987-11       Impact factor: 3.478

View more
  1 in total

1.  Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.

Authors:  Nami Suzuki; Jaeduk Yoshimura Noh; Toshiaki Kameda; Ai Yoshihara; Hidemi Ohye; Miho Suzuki; Masako Matsumoto; Yo Kunii; Kenji Iwaku; Natsuko Watanabe; Koji Mukasa; Ai Kozaki; Toshu Inoue; Kiminori Sugino; Koichi Ito
Journal:  Clin Ophthalmol       Date:  2018-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.